The successful management of patients with malignant lymphoma is dependent upon accurate staging and an appropriate treatment regime. Although the chest is a frequent site of involvement (Chabner, 1977; Filly et al., 1976; Kaplan, 1980; Peckham, 1973; Rosenberg, 1961) , investigation has relied upon the plain chest X-ray (CXR) and tomography (Tomo) until the introduction of computed tomographic scanning (CT scan).
Prognosis has been found to correlate with the presence of very bulky disease in the chest, and even moderate amounts of intrathoracic lymphoma have been associated with a worse response to treatment than would be expected for other sites of involvement (Lee et al., 1980; Mauch et al., 1978) . CT has been found to detect more mediastinal and pulmonary disease (Fong et al., 1982; Muhm et al., 1979; Osbourne et al., 1982; Underwood et al., 1979) in patients with thymoma and bronchial carcinoma, and it has been suggested that it may improve the staging of intrathoracic lymphoma (Ellert & Kreel, 1980) . Comparison has not previously been made with conventional radiography, therefore a prospective study was undertaken to determine the role of thoracic CT in the management of patients with lymphoma.
Patients and methods

Patients
One hundred consecutive, previously untreated True negative investigations Those which were normal at presentation and remained so at follow up examination with no clinical evidence of disease elsewhere.
False negative investigations Those which were contradicted by other radiological findings which fulfilled the true positive criteria.
Results
Comparison of the results from CXR, tomography and CT scan In all instances CT scan proved to be the most sensitive and CXR the least sensitive method for detecting intrathoracic lymphoma. The results of conventional tomography were intermediate between those of CXR and CT scan but never significantly more sensitive than the CXR. Tomography was therefore stopped after the first 50 patients (Table II) . The findings from CXR and CT scan differed most significantly in the mediastinum (P<0.001 for 100 patients (Figure 1 ; Tables III and IV) ). The increased detection by the CT scan was particularly Table V) . CT scan, although more sensitive than CXR, was no more accurate at detecting hilar lymphadenopathy than tomography (Table IV) . This was due to the difficulty experienced with all methods in differentiating enlarged nodes from hilar vessels.
False positives in the mediastinum (Tables II and  III) were due to prominent vessels in all four cases as shown by i.v. contrast enhancement of the CT scans (Figure 2) . Similarly at the hilum four of the false positives were due to vessels and one, on tomography, to a large anterior mediastinal mass which was wrongly interpreted as involving the hila.
Pulmonary parenchymal disease was detected with greater sensitivity by the CT scan compared with the CXR (P<0.05, Table IV ). All 4 patients in whom CT scanning detected occult parenchymal disease had NHL with no other evidence of extranodal spread (Figure 3) . Biopsy confirmation was obtained in 2 of these 4 patients.
Intrathoracic lymphoma was found in 46/100 patients. The overall incidence of involvement by site within the chest was: anterior mediastinum 37%, posterior mediastinum 11%, paratracheal 11 %, paraoesophageal 1 %, carinal 1 %, pericardiac 2%, parenchyma 15%, pleural effusion 13%, and pleural plaques 4%. All those with parenchymal disease has mediastinal or hilar lymphadenopathy and all those with pleural invasion had extensive disease within the chest.
Effect of CT scanning on staging and treatment Thirty-nine patients had evidence of Stage IV disease prior to CT scanning and thus neither stage nor the treatment was affected by the CT scan.
There was a change in stage in 10/61 patients with Stage I-III disease (16%) due to information solely available from the CT scan. The stage was increased in 9 patients: 4 from II-IV by the detection of parenchymal deposits (2 confirmed on biopsy), 3 from I-IT, and 2 from II-III by the detection of intrathoracic lymphadenopathy. Stage was decreased in one patient from III-I when the CT scan demonstrated that a mediastinal shadow was due to normal vascular structures. Thirty-two Stage 1-111 patients had either B symptoms or very large intrathoracic masses for which chemotherapy is our current treatment of choice, and treatment was not therefore affected by CT scan results. Treatment was changed in 11 of the remaining 29 patients (38%). Four required chemotherapy for parenchymal deposits and one (downgraded from III to I) received involved field radiotherapy for an inguinal deposit. Six other patients receiving radiotherapy to the involved field for NHL had the field changed by CT scanning (includes one patient in whom the stage was not changed). No change was made in those with localised HD as all received mantle field radiation which adequately covered any additional sites.
CT scanning and remission assessment (Table VI) Complete remission was achieved by CXR criteria in 28/46 patients with intrathoracic lymphoma, although the CT scan returned to normal in only 18. There have been 9 relapses from the 28 with normal CXR (32%) of which 6 were correctly identified by the remission CT scan as having residual disease after treatment. In comparison, only 3/18 (17%) in whom the CT scan became normal have relapsed.
However, a positive CT scan following treatment did not always represent residual disease. Eight of the 28 in whom the CT scan was still positive have not relapsed in 2 years. A post treatment laparotomy was performed in one patient ( Figure  4 ) with marked residual abnormalities, but only fibrotic and hylanised tissue was found. The addition of CT scanning to the investigation of the chest increased the frequency with which intrathoracic lymphoma could be detected to 46% in newly diagnosed patients, greater than hitherto reported (Chabner et al., 1977; Filly et al., 1976; Kaplan, 1980; Peckham, 1973; Rosenberg, 1961) .
CT scan was shown to be the most sensitive technique in the assessment of mediastinal and parenchymal disease particularly in patients with NHL but also in HD. However CT scan displayed only a small advantage over CXR or tomography at the hilum as has been found for other tumours within the chest (Fong et al., 1982; Muhm et al., 1979; Osbourne et al., 1982; Underwood et al., 1979; Baron et al., 1981) . The low incidence of pericardial and pleural infiltration reflects the early stage in the disease at which most of these patients had been diagnosed.
The additional information from CT scan changed the stage in 10 patients and the treatment in 11. The relative importance of these numbers, however, becomes more apparent when the size of the group "at risk" is taken into account; i.e. change in stage 10/61 (16%), change in treatment 11/29 (38%). This compares favourably with the yield from other staging procedures such as lymphography or bone marrow biopsy (Chabner et al., 1977; Kaplan, 1980) . The value of CT scanning at remission assessment was more difficult to quantify, particularly as relapse was the only positive criterion available. The return of the CT scan to normal was a better prognostic factor than CXR. However, residual abnormalities on CT scan after treatment did not always represent active disease, as has been found at post treatment laparotomy (Sutcliffe et al., 1982) .
In conclusion, the greater sensitivity and specificity of the chest CT scan produced changes in staging and treatment which were most relevant to the management of those patients with localised disease or only minor abnormalities by conventional chest radiology. Further follow up will be necessary to assess the relevance of CT scan at remission assessment. The difficulty in providing a CT scanning service for the routine staging of these patients with malignant lymphoma argues for the greater concentration of lymphoma treatment in specialist centres.
